- Home
- CCIF vs XTNT Comparison
CCIF vs XTNT Comparison
Compare CCIF & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIF
- XTNT
- Stock Information
- Founded
- CCIF 2011
- XTNT N/A
- Country
- CCIF United States
- XTNT United States
- Employees
- CCIF N/A
- XTNT N/A
- Industry
- CCIF Finance/Investors Services
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCIF Finance
- XTNT Health Care
- Exchange
- CCIF Nasdaq
- XTNT Nasdaq
- Market Cap
- CCIF 111.5M
- XTNT 112.1M
- IPO Year
- CCIF N/A
- XTNT N/A
- Fundamental
- Price
- CCIF $5.28
- XTNT $0.92
- Analyst Decision
- CCIF
- XTNT
- Analyst Count
- CCIF 0
- XTNT 0
- Target Price
- CCIF N/A
- XTNT N/A
- AVG Volume (30 Days)
- CCIF 76.9K
- XTNT 355.4K
- Earning Date
- CCIF 01-01-0001
- XTNT 11-07-2025
- Dividend Yield
- CCIF 25.90%
- XTNT N/A
- EPS Growth
- CCIF N/A
- XTNT N/A
- EPS
- CCIF N/A
- XTNT N/A
- Revenue
- CCIF N/A
- XTNT $127,766,000.00
- Revenue This Year
- CCIF N/A
- XTNT $13.03
- Revenue Next Year
- CCIF N/A
- XTNT N/A
- P/E Ratio
- CCIF N/A
- XTNT N/A
- Revenue Growth
- CCIF N/A
- XTNT 15.16
- 52 Week Low
- CCIF $7.43
- XTNT $0.33
- 52 Week High
- CCIF $10.16
- XTNT $0.94
- Technical
- Relative Strength Index (RSI)
- CCIF 40.39
- XTNT 72.89
- Support Level
- CCIF $5.17
- XTNT $0.68
- Resistance Level
- CCIF $5.29
- XTNT $0.89
- Average True Range (ATR)
- CCIF 0.13
- XTNT 0.07
- MACD
- CCIF 0.00
- XTNT 0.01
- Stochastic Oscillator
- CCIF 31.22
- XTNT 90.47
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.